Abstract: Provided is a separation and recovery apparatus for continuously separating and recovering, from a resin mixture containing a resin containing a hydrolyzable polymer and a resin containing a nonhydrolyzable polymer, a hydrolytic component a of the hydrolyzable polymer A and the nonhydrolyzable polymer B, the apparatus including: a crushing unit that crushes the resin mixture a melting/discharging unit that melts a crushed product obtained by the crushing unit to form a fluid and discharges the fluid at a high pressure; and a hydrothermal reaction treatment unit that continuously subjects the fluid discharged from the melting/discharging unit to a hydrothermal reaction treatment, wherein, in the melting/discharging unit, the hydrolyzable polymer A is hydrolyzed, and the hydrolytic component a thereof is dissolved and transferred into water permeating a sintered alloy diaphragm, thereby separating the nonhydrolyzable polymer B.

Abstract: An autonomous moving apparatus includes a moving unit that moves the autonomous moving apparatus, a detector that detects distances from surrounding objects and shapes of the surrounding objects, a notifying unit that notifies surrounding persons, and a controller that controls the moving unit so that the autonomous moving apparatus moves so as to follow movement of a person recognized as a follow target by the detector and, when the person recognized as the follow target performs a specific action, controls the notifying unit to give a notification by a preset notification method in response to the specific action.

Abstract: A magnetic detector comprises a first magnetic sensor configured to measure a first magnetic field component, a second magnetic sensor configured to measure a possible magnetic field component, a processor, and a memory configured to store a program. The program comprises closest proximity detection processing of detecting a timing at which the magnetic body passes a closest proximity position, closest proximity position component acquisition processing of acquiring the first magnetic field component measured at the timing and the possible magnetic field component, predetermined position component acquisition processing of acquiring the first magnetic field component when the magnetic body is at a predetermined position, distance estimation processing of estimating a third direction distance, and magnetic moment amount estimation processing of estimating a magnitude of the magnetic moment.

Abstract: An object of the present invention is to provide a wheel drive device capable of suppressing a temperature increase in an electric motor and a power conversion device and suppressing occurrence of a failure of an electric component. Provided are: an electric motor having a stator 60 and a rotor 40; a stator holder 80 that holds the stator 60; a power conversion device 100 that converts power supplied to the electric motor; and a wheel which accommodates the electric motor, the stator holder 80, and the power conversion device 100 on the inner peripheral side. The stator holder 80 includes a flow path 90 through which a cooling medium flows. The flow path 90 is arranged between the stator 60 and the power conversion device 100.

Abstract: As an antitumor drug which is excellent in terms of antitumor effect and safety, there is provided an antibody-drug conjugate in which an antitumor compound represented by the following formula is conjugated to an antibody via a linker having a structure represented by the following formula: -L1-L2-LP-NH—(CH2)n1-La-Lb-Lc- wherein the antibody is connected to the terminal of L1, and the antitumor compound is connected to the terminal of Lc with the nitrogen atom of the amino group at position 1 as a connecting position.

Abstract: An ophthalmic instrument including a light emitter, an optical system, and a control section. The light emitter includes a light source including at least one out of a first light source unit or a second light source unit that emits light for examining a subject eye. The light emitter is configured to emit light from the light source. The optical system guides light emitted from the light emitter onto a right-eye retina and/or onto a left-eye retina. The control section is configured to control the light emitter and the optical system such that the light is shone onto the right-eye retina and/or onto the left-eye retina.

Abstract: As an antitumor drug which is excellent in terms of antitumor effect and safety and has an excellent therapeutic effect, there is provided an antibody-drug conjugate in which an antitumor compound represented by the following formula is conjugated to an anti-HER2 antibody via a linker having a structure represented by the following formula: -L1-L2-LP-NH—(CH2)n1-La—(CH2)n2—C(?O)—wherein the anti-HER2 antibody is connected to the terminal L1, and the antitumor compound is connected to the carbonyl group of the —(CH2)n2—C(?O)— moiety with the nitrogen atom of the amino group at position 1 as the connecting position.

Abstract: As an antitumor drug which is excellent in terms of antitumor effect and safety and has an excellent therapeutic effect, there is provided an antibody-drug conjugate in which an antitumor compound represented by the following formula is conjugated to an anti-HER2 antibody via a linker having a structure represented by the following formula: -L1-L2-LP-NH—(CH2)n1-La-(CH2)n2-C(?O)— wherein the anti-HER2 antibody is connected to the terminal L1, and the antitumor compound is connected to the carbonyl group of the —(CH2)n2-C(?O)— moiety with the nitrogen atom of the amino group at position 1 as the connecting position

Abstract: As an antitumor drug which is excellent in terms of antitumor effect and safety, there is provided an antibody-drug conjugate in which an antitumor compound represented by the following formula is conjugated to an antibody via a linker having a structure represented by the following formula: -L1-L2-LF-NH—(CH2)n1-La-Lb-Lc- wherein the antibody is connected to the terminal of L1, and the antitumor compound is connected to the terminal of Lc with the nitrogen atom of the amino group at position 1 as a connecting position.

Abstract: A measurement device measures changes over time of a concentration of a measurement substance that occurs due to a reaction occurring as a result of a solution containing the analyte being dripped onto an electrode, by measuring an electric current that occurs due to electrolysis of the measurement substance. The measurement device applies a first voltage over a first application time period. The measurement device measures a first electric current flowing due to an application of the first voltage. The measurement device applies a second voltage over a second application time period. The measurement device a second electric current flowing due to an application of the second voltage. The measurement device uses the first electric current to normalize the second electric current and measures a concentration of the measurement substance that has changed based on the reaction or a concentration of the analyte that has changed based on the reaction.

Abstract: As an antitumor drug which is excellent in terms of antitumor effect and safety and has an excellent therapeutic effect, there is provided an antibody-drug conjugate in which an antitumor compound represented by the following formula is conjugated to an anti-HER2 antibody via a linker having a structure represented by the following formula: -L1-L2-LP-NH—(CH2)n1-La-(CH2)n2-C(?O)— wherein the anti-HER2 antibody is connected to the terminal L1, and the antitumor compound is connected to the carbonyl group of the —(CH2)n2-C(?O)— moiety with the nitrogen atom of the amino group at position 1 as the connecting position.

Abstract: A motor can be controlled in a user-friendly manner so that a phase current based on an input command torque command value is caused to flow to at least one among U-phase, V-phase, and W-phase windings of the motor, so that a predetermined in-phase current is superimposed on the phase current and caused to flow to at least one among the windings. The motor is controlled such that energization to one winding corresponding to a predetermined energization stop phase is stopped, for example, so that energization to the U-phase winding is stopped, and so that a V-phase current, a W-phase current and an in-phase current are caused to flow to each winding corresponding to a phase other than the energization stop phase, for example, so that the V-phase current, the W-phase current and the in-phase current are caused to flow to the V-phase winding and the W-phase winding.

Abstract: A magnetic detector comprises a first magnetic sensor configured to measure a first magnetic field component, a second magnetic sensor configured to measure a possible magnetic field component, a processor, and a memory configured to store a program. The program comprises closest proximity detection processing of detecting a timing at which the magnetic body passes a closest proximity position, closest proximity position component acquisition processing of acquiring the first magnetic field component measured at the timing and the possible magnetic field component, predetermined position component acquisition processing of acquiring the first magnetic field component when the magnetic body is at a predetermined position, distance estimation processing of estimating a third direction distance, and magnetic moment amount estimation processing of estimating a magnitude of the magnetic moment.

Abstract: An object of the present invention is to provide a wheel drive device capable of suppressing a temperature increase in an electric motor and a power conversion device and suppressing occurrence of a failure of an electric component. Provided are: an electric motor having a stator 60 and a rotor 40; a stator holder 80 that holds the stator 60; a power conversion device 100 that converts power supplied to the electric motor; and a wheel which accommodates the electric motor, the stator holder 80, and the power conversion device 100 on the inner peripheral side. The stator holder 80 includes a flow path 90 through which a cooling medium flows. The flow path 90 is arranged between the stator 60 and the power conversion device 100.

Abstract: As an antitumor drug which is excellent in terms of antitumor effect and safety and has an excellent therapeutic effect, there is provided an antibody-drug conjugate in which an antitumor compound represented by the following formula is conjugated to an anti-HER2 antibody via a linker having a structure represented by the following formula: -L1-L2-LP-NH—(CH2)n1-La-(CH2)n2-C(?O)— wherein the anti-HER2 antibody is connected to the terminal L1, and the antitumor compound is connected to the carbonyl group of the —(CH2)n2-C(?O)— moiety with the nitrogen atom of the amino group at position 1 as the connecting position.

Abstract: A magnetic sensor comprises a magnetic material portion; an excitation portion; and a magnetic detection portion, the magnetic sensor detecting a magnetic field by the magnetic detection portion detecting a detection magnetic field generated due to magnetic moments of the magnetic material portion. The excitation portion is configured to include a conductive material formed into an elongated shape, the magnetic material portion is a soft magnetic film formed on a surface of the conductive material, and the magnetic moments of the magnetic material portion are oriented along circumferential directions of the conductive material orthogonal to a longitudinal direction of the conductive material such that the magnetic moments directed to one of the circumferential directions and the magnetic moments direction in another circumferential direction opposite to the one circumferential direction are distributed in substantially equal amounts.

Abstract: As an antitumor drug which is excellent in terms of antitumor effect and safety and has an excellent therapeutic effect, there is provided an antibody-drug conjugate in which an antitumor compound represented by the following formula is conjugated to an anti-HER2 antibody via a linker having a structure represented by the formula: L1-L2-LP-NH—(CH2)n1-La-Lb-Lc or -L1-L2-LP- wherein the anti-HER2 antibody is connected to the terminal L1, and the antitumor compound is connected to the terminal Lc or LP with the nitrogen atom of the amino group at position 1 as the connecting position.

Abstract: Pulsating current (ripple) is generated in a zero-phase current to increase a loss. A motor control system includes an inverter which drives a motor which includes windings separately wound around each phase and an inverter control unit which generates an output voltage pulse corresponding to each phase to control the inverter on the basis of a torque command value and a rotor position of the motor. The inverter control unit divides the output voltage pulse of at least one phase of the output voltage pulses into several pulses during one period of the output voltage pulse such that a zero-phase voltage of only one of positive and negative polarities is output several times from the motor in the one pulse period.

Abstract: Pulsating current (ripple) is generated in a zero-phase current to increase a loss. A motor control system includes an inverter which drives a motor which includes windings separately wound around each phase and an inverter control unit which generates an output voltage pulse corresponding to each phase to control the inverter on the basis of a torque command value and a rotor position of the motor. The inverter control unit divides the output voltage pulse of at least one phase of the output voltage pulses into several pulses during one period of the output voltage pulse such that a zero-phase voltage of only one of positive and negative polarities is output several times from the motor in the one pulse period.

Abstract: A measurement device includes a sensing portion and a measuring portion. The sensing portion contains at least a fluorescent material whose emitting of fluorescent light ceases due to an action of a radioactive beam. The measuring portion measures a radiation quantity of the radioactive beam, with which the sensing portion is irradiated, based on an amount of decrease in the intensity of the fluorescent light emitted by the fluorescent material contained in the sensing portion when the radioactive beam acts on at least a portion of the fluorescent material. The fluorescent light is emitted due to irradiation of the fluorescent material by an excitation source.